Granotapide

Overview

Granotapide is an orally active microsomal triglyceride transfer protein ( MTP ) inhibitor. Granotapide reduces the absorption of cholesterol and triglycerides by inhibiting MTP . Granotapide can be used in the research of coronary artery disease, obesity, diabetes mellitus and hypertension.

Application

Products | Products > Disease Areas > Hypertension | Products > Disease Areas > Obesity | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Microsomal Triglyceride Transfer Protein (MTP)

Product Information

• Catalog No.: HY-119220
• CAS No.: 594842-13-4
• Molecular Formula: C39H37F3N2O8
• Molecular Weight: 718.71
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source